Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

ClinChoice Adquire CROMSOURCE, Expandindo sua Presença Global
  • USA - español
  • USA - English
  • India - English
  • USA - Français
  • USA - Deutsch
  • Latin America - español

ClinChoice, a leading global, midsize and rapidly growing contract research organization focused on the deliver of superior quality efficient and effective research services across the development continuum in Pharmaceutics, Vaccines, Medical Devices, Consumer Products, Cosmetics and Nutraceuticals.

News provided by

ClinChoice

Mar 02, 2023, 15:47 ET

Share this article

Share toX

Share this article

Share toX

FILADÉLFIA, XANGAI e VERONA, Itália, 2 de Março de 2023 /PRNewswire/ -- A ClinChoice Medical Development tem o prazer de anunciar a aquisição da CROMSOURCE S.r.l., uma organização de pesquisa contratada de serviço completo com certificação ISO com sede corporativa em Verona, Itália e sua Sede dos EUA em Cary, NC. A CROMSOURCE tem subsidiárias operacionais nos Estados Unidos e em sete países em toda a Europa Ocidental e Oriental, juntamente com funcionários de campo em vários locais na Europa e nos Estados Unidos.

Fundada em 1997, a CROMSOURCE tem um histórico comprovado de suporte a clientes globais farmacêuticos, de biotecnologia e de dispositivos médicos com recursos excepcionais de pesquisa clínica e pessoal. A aquisição fortalecerá a rede global da ClinChoice e aprofundará seus recursos de serviço completo.

O compromisso da ClinChoice com a melhor qualidade e entrega pontual de seus serviços resultou em um forte histórico de execução bem-sucedida de testes e funções clínicas, incluindo biometria, regulamentação, segurança, médica e operações clínicas. A ClinChoice oferece esses serviços nos setores de medicamentos, dispositivos médicos, vacinas, cosméticos e saúde do consumidor, utilizando modelos FSP e baseados em projetos. Como CRO global, a ClinChoice fornece soluções em todo o ciclo de vida de desenvolvimento para empresas farmacêuticas, de biotecnologia, dispositivos médicos e produtos de consumo em todo o mundo. A clientela da empresa vai desde as maiores empresas multinacionais até empresas startups e emergentes. A ClinChoice concluiu mais de 1.500 estudos clínicos em várias áreas terapêuticas, incluindo oncologia, SNC, doenças raras, oftalmologia, metabólica e respiratória, entre outras.

"Estamos entusiasmados em trabalhar com a CROMSOURCE e expandir nossa cobertura na Europa e nos EUA para melhor atender às necessidades de nossos clientes globais, acelerar o desenvolvimento de produtos e dar suporte ao gerenciamento do ciclo de vida. Estrategicamente, a aquisição da CROMSOURCE nos fornece uma equipe altamente experiente de especialistas operacionais e técnicos na Europa e na América do Norte, somando-se às nossas capacidades existentes em desenvolvimento clínico e serviços de soluções de pessoal", disse Ling Zhen, Presidente e CEO Global da ClinChoice.

"A aquisição da CROMSOURCE traz um aprimoramento significativo ao nosso banco de talentos. Ela aprimora nossas capacidades operacionais com hubs de entrega adicionais para complementar nossa rede atual na Europa e nos EUA. Essa fusão também expande nossas ofertas de tecnologia de ciência de dados em muitas áreas, incluindo ensaios clínicos descentralizados e monitoramento baseado em risco", disse John Balian, cofundador e CEO da ClinChoice, Inc, que lidera as operações da empresa nos Estados Unidos, Europa e Sudeste Asiático.

A fundadora e CEO da CROMSOURCE, Oriana Zerbini, MD, observou: "Estamos entusiasmados por combinar a equipe profundamente experiente e talentosa da CROMSOURCE com a da ClinChoice. As duas empresas oferecem sinergias tão claras que foi uma decisão muito fácil se juntar à Ling, John e ao resto da impressionante equipe da ClinChoice. Estamos ansiosos para nos tornarmos o parceiro CRO de escolha para qualquer cliente em qualquer lugar do mundo."

A CROMSOURCE foi assessorada pela Fairmount Partners e a ClinChoice foi representada pela Crosstree Capital.

Sobre a ClinChoice
A ClinChoice é uma CRO clínica global dedicada a oferecer serviços de alta qualidade para empresas biofarmacêuticas, de vacinas, de dispositivos médicos e de produtos de consumo. Esses serviços incluem Operações Clínicas, Gerenciamento de Projetos, Bioestatística, Gerenciamento de Dados, Assuntos Regulatórios e Assuntos Médicos, Farmacovigilância, Cosmetovigilância, Toxicologia, bem como Redação Médica e outros serviços de desenvolvimento de produtos. A ClinChoice tem centros de entrega nos Estados Unidos, Europa, Canadá, China, Índia, Japão e Filipinas, com mais de 4.000 profissionais dedicados.

Sobre a CROMSOURCE
A CROMSOURCE é uma CRO internacional de serviço completo com certificação ISO, especializada em operações clínicas e desenvolvimento e soluções de recursos flexíveis entregues por equipes estáveis de profissionais altamente experientes. A CROMSOURCE opera escritórios em todas as regiões da Europa e América do Norte e realiza projetos em todo o mundo.

Logotipo - https://mma.prnewswire.com/media/1579077/clinchoice_Logo.jpg

FONTE ClinChoice

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.